Live Quote · AMEXLABDFinancial Services· Asset Management - Leveraged

Direxion Daily S&P Biotech Bear 3X ETF

$7.38 7.17%($-0.57)
TickerSpark Score

Limited financial coverage for LABD.

Not enough data to compute a meaningful composite — typical for foreign-listed ADRs, recent IPOs, or thinly-covered small caps. Live quote, chart, and any available stats still render below.

30
Momentum
52-Week Range0% of range
Low
$7.33
Current
$7.38
High
$74.15

About the company

The Direxion Daily S&P Biotech Bull and Bear 3X ETFs are designed to deliver daily investment returns reflecting triple (300%) the performance of the S&P Biotechnology Select Industry Index, or triple its inverse (opposite) performance, before factoring in any fees or expenses. It's important to note, however, that there is no assurance these funds will successfully achieve their intended daily objectives.

IPO
2015
HQ
New York, DE, US

Price Chart

-89.43% · this period
$72.90$40.14$7.38Jul 02Dec 31Jul 02
Valuation
Market Cap
$16.87M
Div Yield
8.80%
Performance & Tape
52W High
$74.15
52W Low
$7.33
50D MA
$12.94
200D MA
$21.19
Beta
-3.18
Avg Volume
6.66M

Get TickerSpark's AI analysis on LABD

Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

Already have an account? Log in

Coverage · LABD

Our LABD coverage

Recent articles, reports, and earnings notes.

On-Demand Research

No research on LABD yet

For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.

Generate LABD report →
Internal Compare

Similar companies

Peers in the same neighborhood.